×
About 3,310 results

ALLMedicine™ Subdural Hematoma Center

Research & Reviews  1,156 results

Effect of Irrigation Fluid Temperature on Recurrence in the Evacuation of Chronic Subdu...
https://doi.org/10.1001/jamaneurol.2022.4133
JAMA Neurology; Bartley A, Bartek J et. al.

Nov 22nd, 2022 - The effect of a physical property of irrigation fluid (at body vs room temperature) on recurrence rate in the evacuation of chronic subdural hematoma (cSDH) needs further study. To explore whether irrigation fluid temperature has an influence on c...

Minimally invasive fibrinolytic treatment and drainage in patients with acute subdural ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678522
Medicine Ryu HS, Hong JH et. al.

Nov 20th, 2022 - The incidence of acute subdural hemorrhage (ASDH), which is often caused by head trauma, is steadily increasing due to an increase in the elderly population and the use of anticoagulants. Urgent surgical treatment is recommended if the patient has...

The Richmond Acute Subdural Hematoma Score: A Validated Grading Scale to Predict Postop...
https://doi.org/10.1227/neu.0000000000002200
Neurosurgery

Nov 16th, 2022 - The Richmond Acute Subdural Hematoma Score: A Validated Grading Scale to Predict Postoperative Mortality: Corrigendum.|2022||surgery,

Reversible Pisa syndrome caused by chronic subdural hematoma in a patient with Parkinso...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664706
BMC Neurology; Igami E, Fujimaki M et. al.

Nov 16th, 2022 - Pisa syndrome (PS), characterized by lateral trunk flexion, is quite common in patients with Parkinson's disease (PD). Patients with PS are older and have a significantly longer disease duration, more severe motor phenotype, ongoing combined treat...

Brain Meningiomas Manifesting as Intracranial Hemorrhage: Comprehensive Systematic Revi...
https://doi.org/10.1016/j.wneu.2022.10.113
World Neurosurgery; Halalmeh DR, Alrashdan M et. al.

Nov 5th, 2022 - To characterize the salient features of hemorrhagic manifestation of meningiomas and to report on the first case of hemorrhagic meningiomatosis. A comprehensive systematic review of the English-language literature was performed using MEDLINE, PubM...

see more →

Drugs  3 results see all →

Clinicaltrials.gov  79 results

The SQUID Trial for the Embolization of the Middle Meningeal Artery for Treatment of Chronic Subdural Hematoma (STEM)
https://clinicaltrials.gov/ct2/show/NCT04410146

Oct 12th, 2022 - The study objective is to provide an assessment of the safety and effectiveness of Middle Meningeal Artery (MMA) embolization with SQUID for the management of Chronic Subdural Hematoma (cSDH).

Embolization of the Middle Meningeal Artery With ONYX™ Liquid Embolic System for Subacute and Chronic Subdural Hematoma
https://clinicaltrials.gov/ct2/show/NCT04402632

Oct 3rd, 2022 - The purpose of this study is to evaluate the safety and efficacy of embolization of the middle meningeal artery (MMA) using the Onyx™ Liquid Embolic System (LES) for treatment of symptomatic subacute or chronic subdural hematoma (SDH)

Covers to Improve Esthetic Outcome After Surgery for Chronic Subdural Hematoma
https://clinicaltrials.gov/ct2/show/NCT03755349

Oct 3rd, 2022 - The clinical-functional result after frontal and parietal burr-hole trepanation for the treatment of chronic subdural hematoma (cSDH) is effective with regards to control of the hematoma and regression of symptoms (headache, decreased vigilance an...

The Finnish Study of Intraoperative Irrigation Versus Drain Alone After Evacuation of Chronic Subdural Hematoma (FINISH)
https://clinicaltrials.gov/ct2/show/NCT04203550

Aug 19th, 2022 - FINISH-trial is a prospective, randomized, controlled, parallel group non-inferiority trial comparing single burr-hole evacuation of chronic subdural hematoma (CSDH) with intraoperative irrigation (IR) and evacuation of CSDH without irrigation (N-...

Use of Tissue Plasminogen Activator in the Clearance of Chronic Subdural Hematomas
https://clinicaltrials.gov/ct2/show/NCT05491356

Aug 8th, 2022 - A chronic subdural hematoma (CSDH) is a collection of blood overlying the brain that can be seen, usually in the elderly with even minimal head trauma. These are usually treated by removing the collection of blood. This can be done through a small...

see more →

News  83 results

New, Simple Technique for Chronic Subdural Hematoma Cuts Recurrence by 50%
https://www.medscape.com/viewarticle/984462

Nov 22nd, 2022 - Using irrigation warmed to body temperature during burr hole evacuation for chronic subdural hematoma (cSDH) cuts the risk for recurrence by more than half compared and should become the standard of care, new research suggests. Results from the mu...

BCMA and CD3 T-cell–Engaging Bispecific Antibody Shows Promise in R/R Multiple Myeloma
https://www.onclive.com/view/bcma-and-cd3-t-cell-engaging-bispecific-antibody-shows-promise-in-r-r-multiple-myeloma

Nov 1st, 2022 - ABBV-383 was effective and well tolerated at all administered doses in patients with relapsed/refractory multiple myeloma, according to safety and efficacy results from an ongoing first-in-human, phase 1 dose-escalation/-expansion study (NCT039337...

Cediranib Plus Olaparib Elicits rPFS Benefit in Metastatic Castration-Resistant Prostate Cancer
https://www.onclive.com/view/cediranib-plus-olaparib-elicits-rpfs-benefit-in-metastatic-castration-resistant-prostate-cancer

Oct 24th, 2022 - The combination of cediranib and olaparib (Lynparza) significantly improved radiographic progression-free survival (rPFS) compared with olaparib monotherapy in patients with metastatic castration-resistant prostate cancer (mCRPC), according to fin...

Bispecific Antibody ABBV-383 Looks to Fill Unmet Need in Heavily Pretreated Multiple Myeloma
https://www.onclive.com/view/bispecific-antibody-abbv-383-looks-to-fill-unmet-need-in-heavily-pretreated-multiple-myeloma

Aug 28th, 2022 - Promising safety and efficacy results were observed with the novel bispecific antibody ABBV-383 in patients with heavily pretreated relapsed or refractory multiple myeloma, according to updated results from a phase 1 trial (NCT03933735) presented ...

Helping patients move forward following traumatic brain injury
https://www.mdedge.com/familymedicine/article/255453/preventive-care/helping-patients-move-forward-following-traumatic
MDedge Family Medicine; Elizabeth A. Imbesi, PhD, ABPP

Jun 15th, 2022 - THE CASE Declan M*, a 42-year-old man, presents as a new patient for general medical care. One year ago, he sustained a severe frontal traumatic brain injury (TBI) when he was hit by a car while crossing a street.

see more →

Patient Education  3 results see all →